Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Mooney

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Alimentary Pharmacology & Therapeutics|March 5, 2014
Commentary: assessing remission in coeliac disease - are deamidated gliadin peptide antibodies the answer?P D Mooney, D S Sanders
Alimentary Pharmacology & Therapeutics|January 23, 2013
Commentary: larazotide acetate - an exciting new development for coeliac patients?P D Mooney, D S Sanders
Journal of Medicinal Chemistry|July 1, 1970
Antitumor activities of some Schiff basesE M Hodnett, P D Mooney
Alimentary Pharmacology & Therapeutics|December 9, 2014
Editorial: is a histological diagnosis mandatory for adult patients with suspected coeliac disease?M Kurien, P D Mooney, D S Sanders
Gut|March 10, 2016
Identifying the 'Right' colon lesionA D Hopper, P D Mooney, A Blakeborough
Neurogastroenterology and Motility|August 14, 2013
Non-celiac gluten sensitivity: clinical relevance and recommendations for future researchP D Mooney, I Aziz, D S Sanders
Journal of Medicinal Chemistry|July 1, 1976
Potential antitumor agents. 13. 4-Methyl-5-amino-1-formylisoquinoline thiosemicarbazoneK C Agrawal, P D Mooney, A C Sartorelli
Neurogastroenterology and Motility|July 30, 2015
Are we underestimating the prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome?P D Mooney, J Hayman, G Pickering, et al.
Alimentary Pharmacology & Therapeutics|August 24, 2012
Commentary: tioguanine in the treatment of refractory coeliac diseaseP D Mooney, D S Sanders, M Hadjivassilou, et al.
Alimentary Pharmacology & Therapeutics|February 5, 2016
Letter: gluten challenge in the era of noncoeliac gluten sensitivity--a change in clinical practice?S A Raju, P D Mooney, I Aziz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|March 5, 2014
Commentary: assessing remission in coeliac disease - are deamidated gliadin peptide antibodies the answer?P D Mooney, D S Sanders
Alimentary Pharmacology & Therapeutics|January 23, 2013
Commentary: larazotide acetate - an exciting new development for coeliac patients?P D Mooney, D S Sanders
Journal of Medicinal Chemistry|July 1, 1970
Antitumor activities of some Schiff basesE M Hodnett, P D Mooney
Alimentary Pharmacology & Therapeutics|December 9, 2014
Editorial: is a histological diagnosis mandatory for adult patients with suspected coeliac disease?M Kurien, P D Mooney, D S Sanders
Gut|March 10, 2016
Identifying the 'Right' colon lesionA D Hopper, P D Mooney, A Blakeborough
Neurogastroenterology and Motility|August 14, 2013
Non-celiac gluten sensitivity: clinical relevance and recommendations for future researchP D Mooney, I Aziz, D S Sanders
Journal of Medicinal Chemistry|July 1, 1976
Potential antitumor agents. 13. 4-Methyl-5-amino-1-formylisoquinoline thiosemicarbazoneK C Agrawal, P D Mooney, A C Sartorelli
Neurogastroenterology and Motility|July 30, 2015
Are we underestimating the prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome?P D Mooney, J Hayman, G Pickering, et al.
Alimentary Pharmacology & Therapeutics|August 24, 2012
Commentary: tioguanine in the treatment of refractory coeliac diseaseP D Mooney, D S Sanders, M Hadjivassilou, et al.
Alimentary Pharmacology & Therapeutics|February 5, 2016
Letter: gluten challenge in the era of noncoeliac gluten sensitivity--a change in clinical practice?S A Raju, P D Mooney, I Aziz, et al.
Pageof 2